Product Information
NYSTATIN-TRIAMCINOLONE CREAM is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2233 per GM under NDC 68180054502. Its NADAC has been published 389 times since Mar 13, 2019.
FDA first approved this application on May 31, 2018. Its Orange Book therapeutic-equivalence code is AT.
The Low Outlier badge above means this manufacturer's average price in the Nystatin and Triamcinolone Acetonide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180054502
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208205FDA Approved
5/31/2018
TE Code
AT
On Market Since
11/29/2018
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE CREAM has been published 389 times since Mar 13, 2019, and over the history we have for it it has declined 77.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2233 per GM |
|---|---|
| All-time high | $1.0028 (Mar 13, 2019) |
| All-time low | $0.2047 (Nov 20, 2024) |
| 52-week high | $0.2808 |
| 52-week low | $0.2127 |
| Median price | $0.4153 |
| Average price | $0.4359 |
| Largest weekly change | +81.7% (Aug 21, 2024) |
| Weeks tracked | 389 |
| Tracking since | Mar 13, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE CREAM, manufactured by Lupin Pharmaceuticals Inc., is $0.2233 per GM (NDC 68180054502), effective Aug 19, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE CREAM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has declined 77.7%. It has been tracked across 389 weekly CMS publications since Mar 13, 2019.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE CREAM?
Since Mar 13, 2019, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has ranged from a low of $0.2047 (Nov 20, 2024) to a high of $1.0028 (Mar 13, 2019), with a median of $0.4153 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE CREAM?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE CREAM, is $0.1893 per GM — about 15% below NYSTATIN-TRIAMCINOLONE CREAM.
Who manufactures NYSTATIN-TRIAMCINOLONE CREAM?
NYSTATIN-TRIAMCINOLONE CREAM (NDC 68180054502) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.